bibliographic resource 1851331 [br/1851331]
https://w3id.org/oc/corpus/br/1851331

is a
title
  • Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
publication date
  • 2013-01-01
contributor
format
identifier
part of